Viewing Study NCT04544995


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2026-01-14 @ 4:47 PM
Study NCT ID: NCT04544995
Status: TERMINATED
Last Update Posted: 2025-07-16
First Post: 2020-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-19
Start Date Type: ACTUAL
Primary Completion Date: 2025-04-23
Primary Completion Date Type: ACTUAL
Completion Date: 2025-04-23
Completion Date Type: ACTUAL
First Submit Date: 2020-09-04
First Submit QC Date: None
Study First Post Date: 2020-09-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-11
Last Update Post Date: 2025-07-16
Last Update Post Date Type: ACTUAL